Patient-specific computational models predict prognosis in B cell lymphoma by quantifying pro-proliferative and anti-apoptotic signatures from genetic sequencing data (2023)
Attributed to:
Therapeutic targeting of refractory/relapsed diffuse large B-cell lymphoma through systems biology
funded by
FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2023.07.10.548371
Publication URI: http://dx.doi.org/10.1101/2023.07.10.548371
Type: Preprint